Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-17

Clinical Trial Update: A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing conservative versus ablative treatment approaches for hyperthyroidism in Graves' Orbitopathy is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pisa | Conditions: Graves' Orbitopathy | Phase 3 | Status: UNKNOWN